{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T05:44:00Z","timestamp":1670391840666},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Isotretinoin (ISO) is a drug which is used for the treatment of severe and refractory acne vulgaris (AV), over the last few decades. The drug has various musculoskeletal side effects. The aim of this study was to investigate relationship between serum 25 hydroxy (OH) vitamin D levels and the ISO-induced musculoskeletal side effects in patients with AV. We included 87 patients receiving ISO and had musculoskeletal symptoms as adverse effect (AE) group. Another 90 patients receiving ISO for AV and had any musculoskeletal complaints were recruited as control (C) group. Locomotor system examination of the patients was performed by the same clinician. Serum 25 OH vitamin D levels of the all participants were measured. Patients in the AE group were divided into three subgroups by serum 25 OH vitamin D levels. Patients with serum 25 OH vitamin D level lower than 10\u2009ng\/ml was classified as Group I, the ones between 10\u201320\u2009ng\/ml as Group II and those higher than 20\u2009ng\/ml were classified as Group III. AE and C groups were similar in terms of age and sex (p\u2009&gt;\u20090.05). There was no statistically significant difference in the mean serum vitamin D levels between two groups (p\u2009=\u20090.17). Also, there was no significant difference in number of arthralgia (p\u2009=\u20090.30), myalgia (p\u2009=\u20090.29), low back pain (p\u2009=\u20090.10) and sacroiliitis (p\u2009=\u20090.17) between three subgroups in AE group. In addition, we found no statistically significant correlation between the serum vitamin D levels and age, cumulative dose of ISO, arthralgia, myalgia and sacroiliitis parameters in AE group (p\u2009&gt;\u20090.05). Serum 25 OH vitamin D levels between the AE and C groups were similar. We also found that no significant difference in musculoskeletal adverse events between AE subgroups. Therefore, it can be concluded that vitamin D deficiency has no effect on the musculoskeletal adverse events in patients receiving ISO.<\/jats:p>","DOI":"10.1038\/s41598-020-59167-0","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T11:02:57Z","timestamp":1581332577000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Serum 25 Hydroxy Vitamin D Level on Isotretinoin-Induced Musculoskeletal Symptoms: A Cross-Sectional Study"],"prefix":"10.1038","volume":"10","author":[{"given":"Cevriye","family":"M\u00fclko\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nermin","family":"Karaosmano\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"issue":"1","key":"59167_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bjd.13462","volume":"172","author":"JK Tan","year":"2015","unstructured":"Tan, J. K. & Bhate, K. A global perspective on the epidemiology of acne. Br. J. Dermatol. 172(1), 3\u201312 (2015).","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"59167_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1067\/mjd.2002.120529","volume":"46","author":"DK Wysowski","year":"2002","unstructured":"Wysowski, D. K., Swann, J. & Vega, A. Use of isotretinoin (Accutane) in the United States: Rapid increase from 1992 through 2000. J. Am. Acad. Dermatol. 46(4), 505\u2013509 (2002).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"10","key":"59167_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00403-007-0777-2","volume":"299","author":"A Akman","year":"2007","unstructured":"Akman, A. et al. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Arch. Dermatol. Res. 299(10), 467\u2013473 (2007).","journal-title":"Arch. Dermatol. Res."},{"issue":"2","key":"59167_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1517\/14740338.3.2.119","volume":"3","author":"A Charakida","year":"2004","unstructured":"Charakida, A., Mouser, P. E. & Chu, A. C. Safety and side effects of the acne drug, oral isotretinoin. Expert Opin. Drug Saf. 3(2), 119\u2013129 (2004).","journal-title":"Expert Opin. Drug Saf."},{"issue":"2","key":"59167_CR5","first-page":"3","volume":"7","author":"JJ Leyden","year":"2014","unstructured":"Leyden, J. J., Del Rosso, J. Q. & Baum, E. W. The Use of Isotretinoin in the Treatment of Acne Vulgaris: Clinical Considerations and Future Directions. J. Clin. Aesthet. Dermatol. 7(2), 3\u201321 (2014).","journal-title":"J. Clin. Aesthet. Dermatol."},{"issue":"1","key":"59167_CR6","doi-asserted-by":"publisher","first-page":"e1442160","DOI":"10.1080\/19381980.2018.1442160","volume":"10","author":"Thomas Jonathan Stewart","year":"2018","unstructured":"Stewart, T. J. & Bazergy, C. Hormonal and dietary factors in acne vulgaris versus controls Dermatoendocrinol, https:\/\/doi.org\/10.1080\/19381980.2018.1442160 (2018).","journal-title":"Dermato-Endocrinology"},{"issue":"4","key":"59167_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/09546634.2016.1230175","volume":"28","author":"DD Demirseren","year":"2017","unstructured":"Demirseren, D. D. et al. The weeks and the cumulative doses of the first adverse events related to oral isotretinoin in acne patients: analysis of 300 patients. Journal of Dermatological Treatment 28(4), 309\u2013313 (2017).","journal-title":"Journal of Dermatological Treatment"},{"key":"59167_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1440-0960.2010.00657.x","volume":"1","author":"M Rademaker","year":"2010","unstructured":"Rademaker, M. Adverse effects of isotretinoin: a retrospective review of 1743 patients started on isotretinoin. Australas J Dermatol. 1, 248\u2013253 (2010).","journal-title":"Australas J Dermatol."},{"issue":"4","key":"59167_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0049-0172(91)90020-Z","volume":"20","author":"RH Knitzer","year":"1991","unstructured":"Knitzer, R. H. & Needleman, B. W. Musculoskeletal syndromes associated with acne. Semin. Arthritis Rheum. 20(4), 247\u2013255 (1991).","journal-title":"Semin. Arthritis Rheum."},{"key":"59167_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0190-9622(08)80256-3","volume":"27","author":"JH Saurat","year":"1992","unstructured":"Saurat, J. H. Side effects of systemic retinoids and their clinical management. J Am. Acad. Dermatol. 27, 23\u201328 (1992).","journal-title":"J Am. Acad. Dermatol."},{"issue":"2","key":"59167_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/15569527.2016.1237521","volume":"36","author":"L Baykal Sel\u00e7uk","year":"2017","unstructured":"Baykal Sel\u00e7uk, L., Aksu Ar\u0131ca, D., Baykal \u015eahin, H., Yayl\u0131, S. & Bahad\u0131r, S. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin. Cutan. Ocul. Toxicol. 36(2), 176\u2013179 (2017).","journal-title":"Cutan. Ocul. Toxicol."},{"issue":"1","key":"59167_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4103\/ijdvl.IJDVL_834_16","volume":"84","author":"NM Dawoud","year":"2018","unstructured":"Dawoud, N. M., Elnady, B. M., Elkhouly, T. & Yosef, A. Adalimumab as a successful treatment for acne fulminans and bilateral acute sacroiliitis with hip synovitis complicating isotretinoin therapy. Indian J. Dermatol. Venereol. Leprol. 84(1), 104\u2013107 (2018).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"59167_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000069849","volume":"206","author":"C Bachmeyer","year":"2003","unstructured":"Bachmeyer, C. et al. Isotretinoin-induced bilateral sacroiliitis. Dermatology 206, 285\u2013286 (2003).","journal-title":"Dermatology"},{"key":"59167_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1365-4632.2009.04334.x","volume":"49","author":"M Barbareschi","year":"2010","unstructured":"Barbareschi, M. et al. Unilateral sacroiliitis associated with systemic isotretinoin treatment. Int. J. Dermatol. 49, 331\u2013333 (2010).","journal-title":"Int. J. Dermatol."},{"key":"59167_CR15","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00296-009-1014-4","volume":"30","author":"AP Rozin","year":"2010","unstructured":"Rozin, A. P., Kagna, O. & Shiller, Y. Sacroiliitis and severe disability due to isotretinoin therapy. Rheumatol Int. 30, 985\u2013986 (2010).","journal-title":"Rheumatol Int."},{"issue":"4","key":"59167_CR16","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1440-0960.2011.00841.x","volume":"53","author":"M Levinson","year":"2012","unstructured":"Levinson, M., Gibson, A. & Stephenson, G. Sacroiliitis secondary to isotretinoin. Australas J. Dermatol. 53(4), 298\u2013300 (2012).","journal-title":"Australas J. Dermatol."},{"issue":"4","key":"59167_CR17","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1111\/pde.12614","volume":"32","author":"Shekhar Neema","year":"2015","unstructured":"Neema, S. et al. Vitamin D Deficiency After Oral Retinoid Therapy for Ichthyosis. Pediatr Dermatol., https:\/\/doi.org\/10.1111\/pde.12614 (2015).","journal-title":"Pediatric Dermatology"},{"issue":"2","key":"59167_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1529-8019.2011.01406.x","volume":"24","author":"DT Ertugrul","year":"2011","unstructured":"Ertugrul, D. T., Karadag, A. S., Tutal, E. & Akin, K. O. Therapeutic hotline. Does isotretinoin have effect on vitamin D physiology and bone metabolism in acne patients? Dermatol Ther. 24(2), 291\u2013295 (2011).","journal-title":"Dermatol Ther."},{"issue":"1","key":"59167_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/jocd.12503","volume":"18","author":"MA El-Hamd","year":"2019","unstructured":"El-Hamd, M. A., El Taieb, M. A., Ibrahim, H. M. & Aly, S. S. Vitamin D levels in acne vulgaris patients treated with oral isotretinoin. J. Cosmet. Dermatol. 18(1), 16\u201320 (2019).","journal-title":"J. Cosmet. Dermatol."},{"issue":"2","key":"59167_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul, F., Erdfelder, E., Lang, A. G. & Buchner, A. G*Power 3: a flexible statistical power analysis program for the social, behavioral,and biomedicalsciences. Behav Res Methods 39(2), 175\u2013191 (2007).","journal-title":"Behav Res Methods"},{"key":"59167_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1753-4887.2008.00104.x","volume":"66","author":"MF Holick","year":"2008","unstructured":"Holick, M. F. Vitamin D: a D-lightful health perspective. Nutr. Rev. 66, 182\u2013194 (2008).","journal-title":"Nutr. Rev."},{"key":"59167_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.2337\/db07-1122","volume":"57","author":"E Hypp\u00f6nen","year":"2008","unstructured":"Hypp\u00f6nen, E., Boucher, B. J., Berry, D. J. & Power, C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrom at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 57, 298\u2013305 (2008).","journal-title":"Diabetes"},{"issue":"4","key":"59167_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4103\/0019-5154.113959","volume":"58","author":"WJ Lee","year":"2013","unstructured":"Lee, W. J., Choi, Y. H., Sohn, M. Y., Lee, S. J. & Kim, D. W. Expression of Inflammatory Biomarkers from Cultured Sebocytes was Influenced by Treatment with Vitamin D. Indian J Dermatol. 58(4), 327 (2013).","journal-title":"Indian J Dermatol."},{"key":"59167_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/nu10101525","author":"A Al-Taiar","year":"2018","unstructured":"Al-Taiar, A. et al. Plasma 25-Hydroxy Vitamin D is not Associated with Acne Vulgaris. Nutrients. https:\/\/doi.org\/10.3390\/nu10101525 (2018).","journal-title":"Nutrients"},{"issue":"3","key":"59167_CR25","first-page":"238","volume":"12","author":"P Toosi","year":"2015","unstructured":"Toosi, P. et al. Serum 25-hydoxy vitamin D levels in patients with acne vulgaris and its association with disease severity. Clin. Cases in Min. Bone Metab. 12(3), 238\u2013242 (2015).","journal-title":"Clin. Cases in Min. Bone Metab."},{"key":"59167_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161162","author":"SK Lim","year":"2016","unstructured":"Lim, S. K. et al. Comparison of vitamin D levels in patients with and without acne; A case-control study combined with a randomised controlled trial. Plos One. https:\/\/doi.org\/10.1371\/journal.pone.0161162 (2016).","journal-title":"Plos One"},{"key":"59167_CR27","doi-asserted-by":"publisher","DOI":"10.4161\/derm.29799","author":"MT Yildizgoren","year":"2015","unstructured":"Yildizgoren, M. T. & Togral, A. K. Preliminary evidence for vitamin D deficiency in nodulocystic acne. Dermatoendocrinol. https:\/\/doi.org\/10.4161\/derm.29799 (2015).","journal-title":"Dermatoendocrinol."},{"key":"59167_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13165","author":"P Acharya","year":"2019","unstructured":"Acharya, P. & Mathur, M. Vitamin D deficiency in patients with acne vulgaris: A systematic review and meta-analysis. Australas J Dermatol. https:\/\/doi.org\/10.1111\/ajd.13165 (2019).","journal-title":"Australas J Dermatol."},{"issue":"4","key":"59167_CR29","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/jn\/116.4.578","volume":"116","author":"TL Frankel","year":"1986","unstructured":"Frankel, T. L., Seshadri, M. S., McDowall, D. B. & Cornish, C. J. Hypervitaminosis A and calcium-regulating hormones in the rat. J Nutr. 116(4), 578\u2013587 (1986).","journal-title":"J Nutr."},{"issue":"1","key":"59167_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5114\/ada.2019.82822","volume":"36","author":"B Mizio\u0142ek","year":"2019","unstructured":"Mizio\u0142ek, B., Bergler-Czop, B., Sta\u0144kowska, A. & Brzezi\u0144ska-Wcis\u0142o, L. The safety of isotretinoin treatment in patients with bone fractures. Postepy Dermatol Alergol. 36(1), 18\u201324 (2019).","journal-title":"Postepy Dermatol Alergol."},{"key":"59167_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jocd.2005.11.001","volume":"9","author":"R Bhambri","year":"2006","unstructured":"Bhambri, R. et al. Changes in bone mineral density following treatment of osteomalacia. J Clin Densitom 9, 120\u2013127 (2006).","journal-title":"J Clin Densitom"},{"issue":"19","key":"59167_CR32","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1056\/NEJM200305083481917","volume":"348","author":"BJ Boucher","year":"2003","unstructured":"Boucher, B. J. Serum retinol levels and fracture risk. N Engl J Med. 348(19), 1927\u20131928 (2003).","journal-title":"N Engl J Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59167-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59167-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59167-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:04:49Z","timestamp":1670310289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59167-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["59167"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-59167-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"9 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2245"}}